Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual atropine for clozapine-induced sialorrhea
IRCT20221101056373N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atropine in hypersalivation (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: sialorrhea. Started Dec 2022; status: completed.
02
Drugs
atropine
03
Conditions
hypersalivation
Beyond the preview
Go deeper on IRCT20221101056373N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221101056373N1.